GLP1R and type 2 diabetes mellitus: GLP-1R agonists (including semaglutide), dual agonist (tirzepatide), and triagonist (retatrutide) have activities of restricting energy intake and adjusting energy distribution for outstanding efficacy in the treatment of T2DM and obesity care [1, 90].